Skip to main content
. 2020 Feb 6;63(2):48–51. doi: 10.3345/kjp.2019.00038

Table 1.

Results of univariate analysis of neonatal, maternal, and placental variables

Variable Full term (n=70) Late preterm (n=90) P value
Placental histopathology
 Chorioamnionitis 35 (50.0) 16 (17.8) <0.001
 Funisitis 14 (20.0) 4 (4.4) 0.002
 Hemorrhage 7 (10.0) 4 (4.4) 0.21
 Placental Abruption 1 (1.4) 4 (4.4) 0.39
 Infarction 10 (14.3) 23 (25.6) 0.08
 Syncytial knots 8 (11.4) 19 (21.1) 0.11
 Calcifications 23 (32.9) 18 (20.0) 0.07
Infant variables
 Birth weight (g) 3,208.8±530.11 2,024.4±518.98 <0.001
 Gestational age (wk) 38.9±1.38 33.0±1.98 <0.001
 Male sex 36 (51.4) 55 (61.1) 0.22
 Race/ethnicity
  White 11 (15.7) 11 (12.2)
  Black 18 (25.7) 24 (26.7)
  Hispanic 36 (51.4) 47 (52.2)
 Other 5 (7.1) 8 (8.9)
 Growth 0.99
  Appropriate for gestational age 59 (84.3) 76 (84.4)
  Large for gestational age 5 (7.1) 6 (6.7)
  Small for gestational age 6 (8.6) 8 (8.9)
Apgar at 1 min 7.3±2.45 7.4±1.89 0.89
Apgar at 5 min 8.2±1.55 8.2±1.10 0.66
Maternal variable
 Age (yr) 28.1±5.99 30.4±6.49 0.02
 Substance abuse 2 (2.9) 3 (3.3) 1.00
 Gestational diabetes mellitus 5 (7.1) 7 (7.8) 0.88
 Maternal hypertension 9 (12.9) 26 (28.9) 0.02
 Magnesium sulfate (maternal treatment) 14 (20.0) 44 (48.9) <0.001
 Antibiotics (maternal treatment) 42 (60.0) 53 (58.9) 0.89
 Duration of rupture of membrane (hr) 13.6±13.54 9.1±15.66 <0.001

Values are presented as number (%) or mean±standard deviation.

Boldface indicates a statistically significant difference with P<0.05.